Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 2037 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 


 
ORIGINAL ARTICLE Table of Contents   
Year : 1996  |  Volume : 7  |  Issue : 3  |  Page : 291-296
Is There an Advantage in Adding Azathioprine to Prednisone and Cyclosporine in Kidney Transplant Recipients?


Department of Nephrology and Dialysis, Al Hada Armed Forces Hospital, Taif, Saudi Arabia

Correspondence Address:
Magdi Hussein
Department of Nephrology and Dialysis, Al Hada Armed Forces Hospital, PO Box 1347 Taif
Saudi Arabia
Login to access the Email id


PMID: 18417945

Rights and Permissions

Some recent studies have raised doubts about the advantage of adding azathioprine to cyclosporine and prednisone ("triple therapy") in kidney transplant patients. We reviewed the charts of 53 patients followed at our center after they received a living non-related kidney transplant in India. Thirty-eight patients used "triple therapy" (cyclosporine, prednisone and azathioprine) and 15 patients "double therapy" (cyclosporine and prednisone). A multi-variate analysis was used to study the differences in gender, age, follow-up period, number of patients with at least one acute rejection episode, number of significant infections, cyclosporine dosage and trough levels, prednisone dosage, transplant function, and graft loss due to rejection. There was no difference in the number of acute rejections or graft loss due to rejection in both treatment groups. Although the mean cyclosporine levels at 6, 12 and 24 months and the mean dosage at 6 and 12 months were significantly lower in the triple therapy group, there was no significant differences in these parameters between the patients with and without rejection. The cyclosporine levels at the time of rejection were also not different from the levels in the patients without rejection. The results support other reports suggesting that azathioprine does not seem to add to the immunosuppressive effect, as it is not associated with a lower incidence of acute rejections or an improved graft survival.


[FULL TEXT] [PDF]*
Print this article  Email this article
    

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1717    
    Printed59    
    Emailed0    
    PDF Downloaded173    
    Comments [Add]    

Recommend this journal